Last updated on: 19/10/2012
Name of organisation
1) Department/Research groupReal World Evidence Solutions
2) Organisation/affiliationIMS Health
Short Name in the inventoryIMS Health
Administrative Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
Phone number (incl. country code)33-1413-51335
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
Phone number (incl. country code)33-1413-51335
Alternative phone number
Fax number (incl. country code)
2. Description
Supported by the most comprehensive, advanced and credential tools and databases available in the world, we carry out two major kinds of research:
1) Conventional ad-hoc epidemiological, pharmacoepidemiological, health economics and safety studies using both observational and interventional methodologies.
2) Innovative studies on Real World Data (RWD): these are databases of de-identified electronic health records gathered over a long period of time from a panel of physicians, pharmacists, hospitals, nurses, etc. This unique source of data helps us designing and conducting a variety of studies directly through the databases. These include safety, and drug utilisation studies, but also studies on diagnoses, acts, patient adherence, therapeutic reasoning, quality of life, and cost of care.
3. Category
For profit organisation
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Clinician
Yes
No
Clinical Pharmacologist
Yes
No
Pharmacist
Yes
No
Geneticist/Pharmacogeneticist
No
Yes
IT specialist
Yes
No
Ethics expertise
Yes
No
Legal expertise
Yes
No
Regulatory expertise
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Anaesthesia
Cardiovascular diseases
Devices
Disorders of the central nervous system
Ear, nose and oropharynx disorders
Endocrine disorders
Eye disorders
Gastrointestinal tract
Geriatrics
Gynaecology
Immunological products and vaccines
Immunosuppression
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Nutrition and blood
Osteoporosis
Paediatrics
Pregnancy
Psychiatry
Renal impairment
Respiratory diseases
Skin disorders
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Interventional Clinical Trial
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Greater than 15000
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
Yes
System used:
Web based system developed in house (ASP .NET Technology)
Interactive voice response systems
Yes
Call centre
Yes
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
GPRD20
IMS Disease Analyzer1000
IMS EPPM1000
IMS Oncology Analyzer1000
IMS EHPM1000
11. Registries established by centre
Drug RegistryIMS Treatment Dynamics
Disease RegistryDiabetes Cohort
Other Oncology Analyzer
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
None
14. Interest in research opportunities which are funded
By pharmaceutical companies
By government
By research councils
By EU funding schemes
15. Interest in contract research only if free to publish results
No
16. Selected publications of the last 5 calendar years
ReferenceLink to web-publication
